Results 101 to 110 of about 928,578 (204)
α-Synuclein accumulation and transmission are vital to the pathogenesis of Parkinson’s disease, although the mechanisms underlying misfolded α-synuclein accumulation and propagation have not been conclusively determined.
Hanjiang Luo +7 more
doaj +1 more source
MOESM1 of CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Additional file 1: Figure S1. Location and standardized of SN position from mouse brain. Figure S2. Levels of inflammatory factors in α-synuclein and ADM3100 treated primary microglia. Figure S3. Expression of CXCR4 in BV-2 cells. (a) Western bolt showed
Aonan Zhao (8121878) +9 more
core +1 more source
A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP [PDF]
Parkinson’s disease (PD) is a neurodegenerative disorder frequent at old age characterized by atrophy of the nigrostriatal projection. Overexpression and A53T-mutation of the presynaptic, vesicle-associated chaperone alpha-synuclein are known to cause ...
Oliver Schmidt +17 more
core +1 more source
This study establishes a universally applicable framework for vesicle surface analysis by combining engineered amyloid‐β‐displaying nanovesicles with machine‐learning‐optimized impedance spectroscopy. Equivalent‐circuit modeling reveals that membrane capacitance correlates with the surface protein states, enabling label‐free quantification of vesicle ...
Jaeyoon Song +5 more
wiley +1 more source
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
In Parkinson’s disease (PD) there is widespread accumulation in the brain of abnormal α-synuclein aggregates forming intraneuronal Lewy bodies (LB). It is now well established that LB-type α-synuclein aggregates also occur in the peripheral autonomic ...
Ariadna Recasens +6 more
doaj +1 more source
A new class of lysosome‐directed molecular glue degraders selectively enhance CAPRIN1–APP interactions, driving APP degradation and reducing amyloid‐β production in human neurons and Alzheimer's disease mouse models. This CAPRIN1‐dependent targeted protein degradation strategy reveals a previously unrecognized therapeutic approach for disrupting the ...
Sunghan Jung +15 more
wiley +1 more source
Dehydroamino acids (DHAA) are atypical electrophilic sites that lead to crosslinked proteins in Alzheimer's disease (AD) brains. No catalyst for their formation has been known in humans. We report that metal oxides catalyze β‐elimination of phosphoserine and phosphothreonine in model peptides at pH 7.5°C and 37°C, yielding DHAAs.
Samuel W. Markovich +3 more
wiley +2 more sources
reservedParkinson's disease (PD) is a neurodegenerative disorder associated with the degeneration of dopaminergic neurons in the substantia nigra pars-compacta. It is characterized by the presence of Lewis Bodies (LBs) inclusions.
RIZZOTTO, ELENA
core
β-Synuclein exhibits chaperone activity more efficiently than α-synuclein [PDF]
β-Synuclein exhibits high sequence homology and structural similarity with α-synuclein, a protein implicated in the pathogenesis of Parkinson's disease.
Choi, Kwan Yong +2 more
core +1 more source
We use lysine‐to‐glutamine mutations to study the effect of electrostatics on the kinetics and thermodynamics of alpha‐synuclein amyloid fibril formation. We find that mutational effects map on their structural context within fibrils and identify residues that modulate the energy landscape of alpha‐synuclein self‐assembly. Our work outlines a scalable,
Antonin Kunka +10 more
wiley +1 more source

